Cargando…

Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020

We aimed to assess the impact of the COVID-19 pandemic on the incidence of vaccine-preventable diseases (VPDs) and participation in the routine infant vaccination programme in the Netherlands. The incidence of various VPDs initially decreased by 75–97% after the implementation of the Dutch COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales:	Middeldorp, Marit, van Lier, Alies, van der Maas, Nicoline, Veldhuijzen, Irene, Freudenburg, Wieke, van Sorge, Nina M., Sanders, Elisabeth A.M., Knol, Mirjam J., de Melker, Hester E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd. 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787078/ https://www.ncbi.nlm.nih.gov/pubmed/33478793 http://dx.doi.org/10.1016/j.vaccine.2020.12.080

Ejemplares similares

Hospitalization due to varicella in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2011)

Pathogen- and Type-Specific Changes in Invasive Bacterial Disease Epidemiology during the First Year of the COVID-19 Pandemic in The Netherlands
por: Steens, Anneke, et al.
Publicado: (2022)

Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2019)

Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2010)

Intention to vaccinate universally against varicella, rotavirus gastroenteritis, meningococcal B disease and seasonal influenza among parents in the Netherlands: an internet survey
por: van Lier, Alies, et al.
Publicado: (2017)

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study
por: Ohm, Milou, et al.
Publicado: (2021)

Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines
por: de Boer, Pieter T., et al.
Publicado: (2018)

More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands
por: Versteegen, Pauline, et al.
Publicado: (2021)

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: Knol, Mirjam J., et al.
Publicado: (2015)

Negative attitude and low intention to vaccinate universally against varicella among public health professionals and parents in the Netherlands: two internet surveys
por: van Lier, Alies, et al.
Publicado: (2016)

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022
por: Huiberts, Anne J, et al.
Publicado: (2023)

Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015
por: Wagenvoort, Gertjan H J, et al.
Publicado: (2017)

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands
por: Thorrington, Dominic, et al.
Publicado: (2018)

Increase in invasive disease caused by Haemophilus influenzae b, the Netherlands, 2020 to 2021
por: Steens, Anneke, et al.
Publicado: (2021)

Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster
por: van Lier, Alies, et al.
Publicado: (2015)

Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
por: Knol, Mirjam J, et al.
Publicado: (2018)

COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021
por: van Ewijk, Catharina E, et al.
Publicado: (2022)

Assessment of vaccine candidates for persons aged 50 and older: a review
por: Eilers, Renske, et al.
Publicado: (2013)

Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011
por: van Lier, Alies, et al.
Publicado: (2016)

Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands
por: Hoes, Joske, et al.
Publicado: (2018)

An evidence synthesis approach to estimating the incidence of symptomatic pertussis infection in the Netherlands, 2005–2011
por: McDonald, Scott A., et al.
Publicado: (2015)

Tolerability of Early Measles-Mumps-Rubella Vaccination in Infants Aged 6–14 Months During a Measles Outbreak in The Netherlands in 2013–2014
por: van der Maas, Nicoline A. T., et al.
Publicado: (2016)

Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021
por: de Gier, Brechje, et al.
Publicado: (2021)

The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015–2018
por: Loenenbach, Anna D, et al.
Publicado: (2020)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: van Deursen, Anna M.M., et al.
Publicado: (2012)

Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology
por: Woudenberg, Tom, et al.
Publicado: (2017)

Pertussis hospitalizations among term and preterm infants: clinical course and vaccine effectiveness
por: van der Maas, Nicoline A. T., et al.
Publicado: (2019)

Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022
por: van Iersel, Senna C.J.L., et al.
Publicado: (2023)

Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands
por: Tielemans, Susanne M A J, et al.
Publicado: (2017)

Determinants of HPV-vaccination uptake and subgroups with a lower uptake in the Netherlands
por: de Munter, A. C., et al.
Publicado: (2021)

Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012
por: Sane, Jussi, et al.
Publicado: (2014)

Effects of Pneumococcal Conjugate Vaccine 2 Years after Its Introduction, the Netherlands
por: Rodenburg, Gerwin D., et al.
Publicado: (2010)

The use of tetanus post-exposure prophylaxis guidelines by general practitioners and emergency departments in the Netherlands: a cross-sectional questionnaire study
por: Donken, Robine, et al.
Publicado: (2014)

Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022
por: Hoeve, Christina E, et al.
Publicado: (2023)

The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands
por: McDonald, Scott A, et al.
Publicado: (2012)

Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
por: de Gier, Brechje, et al.
Publicado: (2023)

Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021
por: de Gier, Brechje, et al.
Publicado: (2021)

Evaluation of the surveillance system for invasive meningococcal disease (IMD) in the Netherlands, 2004–2016
por: Brandwagt, Diederik A. H., et al.
Publicado: (2019)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals
por: Knol, Mirjam J, et al.
Publicado: (2022)

Gender-specific mortality in DTP-IPV- and MMR ± MenC-eligible age groups to determine possible sex-differential effects of vaccination: an observational study
por: Schurink-van’t Klooster, Tessa M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lpnm04kk1i527njb1agjfd1bju